---
title: 'Research Daily Summary: What Happened on November 17, 2026'
headline: Blood test separates advanced Alzheimer’s tau pathology
description: A five-study analysis linked memory gains across generations with lower
  dementia incidence. Parkinson’s researchers completed a 5,500-sample protein analysis.
url: https://thebench.bio/news/research/2026-11-17
topic: research
date: '2026-11-17'
covers:
- '2026-11-17'
date_published: '2026-11-17T12:03:14Z'
date_modified: '2026-11-17T12:03:14Z'
tags:
- Clinical
- Industry
- Manufacturing
- Research
sources: 4
publisher: TheBench.Bio
---

# Research Daily Summary: What Happened on November 17, 2026

**Blood test separates advanced Alzheimer’s tau pathology**

A five-study analysis linked memory gains across generations with lower dementia incidence. Parkinson’s researchers completed a 5,500-sample protein analysis.

## Today in brief

An immunoassay detected advanced tau pathology in Alzheimer’s disease with performance similar to mass spectrometry, using a much smaller plasma sample. [1] Across five long-term studies, people born later had better memory in old age and declined more slowly. [2]

## Also worth knowing

- Researchers investigating a death during a gene-therapy trial did not establish its precise cause and proposed experiments to screen for the newly recognized risk in future therapies. [3]
- The Michael J. Fox Foundation and Thermo Fisher Scientific completed a proteomic analysis of 5,500 Parkinson’s Precision Medicine Initiative samples. Researchers reported early associations between immune markers and genetic Parkinson’s cohorts. [4]

## The day in numbers

- **35 µL**: Plasma used by the eMTBR-tau immunoassay, versus 1.5 mL for mass spectrometry. [1]
- **5,500**: Samples in the completed Parkinson’s proteomic analysis. [4]
- **13% per decade**: Decrease in dementia incidence that the study authors said generational memory gains could plausibly explain. [2]

## Sources

1. [New Blood Test Could Make Measuring Advanced Alzheimer’s Disease More Accessible](<https://www.insideprecisionmedicine.com/topics/molecular-dx/new-blood-test-could-make-measuring-advanced-alzheimers-disease-more-accessible/>), Inside Precision Medicine, 2026-11-17
2. [Generational gains in cognitive capacity and dementia incidence rates in Western countries](<https://www.nature.com/articles/s41591-026-04759-y>), Nature Medicine, 2026-11-17
3. [STAT+: After death in gene therapy trial for a brain disease, progress is reported ](<https://www.statnews.com/2026/11/17/capsida-gene-therapy-trial-death-follow-up-investigation/?utm_campaign=rss>), STAT Biotech, 2026-11-17
4. [Parkinson’s biomarker discovery boosted by new proteomic dataset in the PPMI](<https://www.biotechniques.com/neuroscience/parkinsons-biomarker-discovery-boosted-by-new-proteomic-dataset-in-the-ppmi/>), BioTechniques, 2026-11-17

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.insideprecisionmedicine.com/topics/molecular-dx/new-blood-test-could-make-measuring-advanced-alzheimers-disease-more-accessible/>
[2]: <https://www.nature.com/articles/s41591-026-04759-y>
[3]: <https://www.statnews.com/2026/11/17/capsida-gene-therapy-trial-death-follow-up-investigation/?utm_campaign=rss>
[4]: <https://www.biotechniques.com/neuroscience/parkinsons-biomarker-discovery-boosted-by-new-proteomic-dataset-in-the-ppmi/>
